NOKOMIS, Fla.--(BUSINESS WIRE)-- <\/p>\n
As part of its mission to capture a share of the fast-growing, $232 billion personalized medicine market, Rainbow Coral Corp. (RBCC) is making plans to empower patients to demand better care through a potent combination of innovation and education. <\/p>\n
By delivering new technologies in the sectors of the personalized medicine field poised for the most growthincluding companion diagnosticsRBCC hopes to arm patients with more effective and efficient treatment options than ever before. But bringing new ideas and products to the marketplace is only one piece of the companys strategy for expansion, says RBCC CEO Patrick Brown. <\/p>\n
Our ultimate goal is to help spur patient-driven demand for personalized medicine, Brown said. That requires not just delivering new innovations, but helping to educate patients on these promising new treatment options. Thats why were developing a comprehensive media and marketing strategy. <\/p>\n
The personalized medicine market in the U.S. is ripe for expansion, with PricewaterhouseCoopers predicting that the sector could grow to as much as $452 billion by 2015. One of the fastest-growing fields in the market is companion diagnostics, which could grow to as large as $42 billion by 2015, according to industry analysts TriMarkPublications.com. <\/p>\n
RBCC has formed a biotech subsidiary, Rainbow BioSciences, to market and develop new medical and research technology innovations to compete alongside companies such as Bristol Myers Squibb Co. (NYSE:BMY),Biogen Idec Inc. (NASDAQ:BIIB), Abbott Laboratories (NYSE:ABT) and Amgen Inc. (NASDAQ:AMGN). <\/p>\n
For more information on RBCCs other biotech initiatives, please visitwww.rainbowbiosciences.com\/investors.html. <\/p>\n
About Rainbow BioSciences <\/p>\n
Rainbow BioSciences, LLC, is a wholly owned subsidiary of Rainbow Coral Corp. (OTCBB:RBCC). The Company continually seeks out new partnerships with biotechnology developers to deliver profitable new medical technologies and innovations. For more information on our growth-oriented business initiatives, please visitwww.RainbowBioSciences.com. For investment information and performance data on the Company, please visitwww.RainbowBioSciences.com\/investors.html. <\/p>\n
Notice Regarding Forward-Looking Statements <\/p>\n
<\/p>\n
Visit link:<\/p>\n
RBCC to Drive Growth Through Personalized Medicine<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" NOKOMIS, Fla.--(BUSINESS WIRE)-- As part of its mission to capture a share of the fast-growing, $232 billion personalized medicine market, Rainbow Coral Corp. Continue reading